Necrotizing Enterocolitis clinical trials at UCSF
1 research study open to eligible people
Necrotizing enterocolitis is a serious disease causing bowel tissue damage in newborns. UCSF is studying an Eclipse system to increase bowel length in patients with short bowel syndrome. This research seeks to understand the system's safety and possible benefits.
Showing trials for
Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
open to eligible people ages 3 months to 65 years
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
San Francisco, California and other locations
Our lead scientists for Necrotizing Enterocolitis research studies include Matthew Lin, MD.
Last updated: